DR Congo: Ebola vaccination campaign launched in Kisangani, with effectiveness yet to be assessed
An Ebola vaccination campaign has begun in Kisangani, Democratic Republic of Congo. The vaccine being used targets the Zaire strain, while the current outbreak has been attributed to the Bundibugyo strain.
Ebola vaccination has begun in Kisangani, Democratic Republic of Congo (DRC), amid an outbreak affecting six provinces of the country.
However, uncertainty remains over the protection provided by the administered product. The vaccine used targets the Zaire strain of the Ebola virus, while the current outbreak is linked to the Bundibugyo strain.
Effectiveness against the circulating strain yet to be determined
The effectiveness of this vaccine against the Bundibugyo strain therefore remains to be assessed. Available information does not make it possible to establish its level of protection against this variant responsible for the current outbreak.
The launch of the campaign in Kisangani comes as six Congolese provinces are affected, according to information reported by France 24.
Join the conversation
Reader comments are shown in their original language.